AR045491A1 - Derivados de bencimidazol sustituidos con haloalquilo y piperidina - Google Patents

Derivados de bencimidazol sustituidos con haloalquilo y piperidina

Info

Publication number
AR045491A1
AR045491A1 ARP040103048A ARP040103048A AR045491A1 AR 045491 A1 AR045491 A1 AR 045491A1 AR P040103048 A ARP040103048 A AR P040103048A AR P040103048 A ARP040103048 A AR P040103048A AR 045491 A1 AR045491 A1 AR 045491A1
Authority
AR
Argentina
Prior art keywords
het
alkyl
haloalkyl
aryl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Suspension/Interruption
Application number
ARP040103048A
Other languages
English (en)
Inventor
Birke Franz Dr
Bouyssou Thierry Dr
Dollinger Horst Dr
Martyres Dominic Dr
Pouzet Pascale Dr
Anderskewitz Ralf Dr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of AR045491A1 publication Critical patent/AR045491A1/es
Suspension/Interruption legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
    • C04B35/632—Organic additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Ceramic Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de la fórmula general (1), en donde: R1 es arilo, Het o una especie condensada del mismo, en donde Het es un anillo heterocíclico y la especie condensada comprende condensaciones arilo-het, het-arilo o het-het, pudiendo estar cada uno de dichos arilo o het sustituidos con uno, dos o tres R2; R2 son, cada uno independientemente, -alquilo C1-6, -cicloalquilo C3-6, -haloalquilo C1-6, -aralquilo C1-6, halógeno, -CN-, -COOR3, -COR3, -CONR3R4, -NR3R4, -NR3COR4, -NR3SO2R4, -OR3, -NO2, - SR3, -SOR3, -SO2R3 o -SO2NR3R4; R3 es H, -alquilo C1-6, -cicloalquilo C3-8, (-cicloalquil C3-8)-alquilo(C1-6) o -haloalquilo C1-6; R4 es H, -alquilo C1-6, -cicloalquilo C3-8, (-cicloalquil C3-8)-alquilo(C1-6) o -haloalquilo C1-6; R3 y R4, junto con el átomo de nitrógeno situado entremedias o un grupo -N-SO2, forman un anillo de 3 a 8 miembros heterocíclico, que contiene nitrógeno, opcionalmente sustituido; R5 es -haloalquilo C1-6; R6 son, cada uno independientemente, -alquilo C1-6, -alcoxi C1- 6, -aciloxi C1-6, -aralquilo C1-6, -cicloalquilo C3-6, -haloalquilo C1-6, -tioalquilo C1-6, halógeno, OR3, -SR3, -CN, -NO2, -COOR3, -COR3, -CONR3R4, -NR3R4, -NR3R4, -NR3COR4, -NR3SO2R4, -SOR3, -SO2R3, -SO2NR3R4, arilo o het; A es -alquileno C2-8, opcionalmente sustituido con -alquilo C1-3, halógeno u -OH; B es arilo o het; Y es un enlace, -CH2; -CF2-, -NR4-, -O-, -S(O)n-; i y j son, cada uno independientemente, 1, 2 ó 3; n es 0, 1 ó 2; m es 0, 1, 2, 3 ó 4. Es otro objeto del presente es proporcionar composiciones farmacéuticas que comprendan un soporte farmacéuticamente aceptable y una cantidad terapéuticamente eficaz de al menos uno de los compuestos del presente o una sal farmacéuticamente aceptable del mismo.
ARP040103048A 2003-08-25 2004-08-25 Derivados de bencimidazol sustituidos con haloalquilo y piperidina Suspension/Interruption AR045491A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03018705 2003-08-25

Publications (1)

Publication Number Publication Date
AR045491A1 true AR045491A1 (es) 2005-11-02

Family

ID=34203215

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103048A Suspension/Interruption AR045491A1 (es) 2003-08-25 2004-08-25 Derivados de bencimidazol sustituidos con haloalquilo y piperidina

Country Status (11)

Country Link
EP (1) EP1660476B1 (es)
JP (1) JP4783286B2 (es)
AR (1) AR045491A1 (es)
AT (1) ATE349441T1 (es)
CA (1) CA2536787C (es)
DE (1) DE602004003965T2 (es)
ES (1) ES2279423T3 (es)
PE (1) PE20050369A1 (es)
TW (1) TW200514778A (es)
UY (1) UY28490A1 (es)
WO (1) WO2005019203A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE531706T1 (de) 2005-04-30 2011-11-15 Boehringer Ingelheim Int Neue piperidin-substituierte indole und ihre verwendung als ccr-3-modulatoren
EP1948324B1 (en) * 2005-11-15 2010-12-01 Latchways PLC Safety device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB0005642D0 (en) * 2000-03-10 2000-05-03 Astrazeneca Uk Ltd Chemical compounds

Also Published As

Publication number Publication date
EP1660476A1 (en) 2006-05-31
PE20050369A1 (es) 2005-06-24
CA2536787C (en) 2012-02-21
ES2279423T3 (es) 2007-08-16
DE602004003965T2 (de) 2007-04-26
DE602004003965D1 (de) 2007-02-08
TW200514778A (en) 2005-05-01
JP4783286B2 (ja) 2011-09-28
WO2005019203A1 (en) 2005-03-03
CA2536787A1 (en) 2005-03-03
ATE349441T1 (de) 2007-01-15
UY28490A1 (es) 2005-03-31
EP1660476B1 (en) 2006-12-27
JP2007503411A (ja) 2007-02-22

Similar Documents

Publication Publication Date Title
AR049894A1 (es) Derivados de prolina y sus usos como inhibodores de la enzima dipeptidilpeptidasa-iv
AR060618A1 (es) Compuesto de ciclohexilpirazol-lactama composicion farmaceutica que comprende dicho compuesto su uso para la preparacion de un medicamento e intermediarios para prepararlo
AR044614A1 (es) Composiciones de sulfonamida que modulan la actividad del receptor de quinioquinas (ccr4)
YU48854B (sh) Derivati n-(4-piperidinil) (dihidrobenzofuran ili dihidro-2h-benzopiran)karboksamida i postupak za njihovo dobijanje
AR084720A1 (es) Inhibidores de anillos fusionados triciclicos de hepatitis c
EA200800476A1 (ru) Макроциклические ингибиторы вируса гепатита с
CO5640152A2 (es) Composiciones farmaceuticas para inhibidores de la proteasa del virus de la hepatitis c
AR068140A1 (es) Amidas heterociclicas y metodos de uso de las mismas
AR060173A1 (es) Derivados de piridina y de pirimidina como antagonistas del mglur2, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de trastornos del snc.
AR051469A1 (es) Derivados de indol tetraciclicos como agentes antiviricos
AR082696A1 (es) Derivados heterociclicos nitrogenados de 1,2,4-oxadiazol, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades cardiovasculares e inflamatorias, entre otras
AR065891A1 (es) Derivados de piridina y pirimidina como antagonistas del mglur2
AR068376A1 (es) Amidas heterociclicas utiles para inhibir la via hedgehog.
EA200970379A1 (ru) Бициклические гетероароматические соединения
AR050435A1 (es) DERIVADOS DE HIDROXIAMIDA, PROCESOS DE OBTENCIoN Y COMPOSICIONES FARMACÉUTICAS.
AR064414A1 (es) Derivados de 1-azoniabiciclo[2, 2, 2]octano y 1-azabiciclo[2, 2, 2]oct-3-ilo, un proceso para su preparacion, una composicion farmaceutica que los comprende, procedimiento de obtencion de la misma, su uso en la elaboracion de un medicamento para el tratamiento de epoc y un producto farmaceutico que
CO5031250A1 (es) Compuesto farmaceutico
CO6210701A2 (es) Derivados de amidas del acido 6,7-dihidro-5h-imidazo[1,2-a]imidazol-3-carboxilico
AR049861A1 (es) Derivados de bencimidazol, procesos de preparacion y composiciones farmaceuticas que los co0ntienen.
AR077525A1 (es) 4-aril-butan-1,3-diamidas y composiciones farmaceuticas
AR054266A1 (es) Indoles sustituidos con piperidina
ATE335050T1 (de) Squaryliumverbindungen vom metallkomplex-typ sowie optische aufzeichnungsmedien hergestellt unter verwendung derselben
AR081377A1 (es) Compuestos de pirazolopiridina bifuncionales
AR063357A1 (es) Derivados de pirimidinas como inhibidores de mapk/erk quinasa. procesos de obtencion y composiciones farmaceuticas.
NO874330L (no) Mellomprodukter.

Legal Events

Date Code Title Description
FB Suspension of granting procedure